Low‐dose isotretinoin for difficult‐to‐treat rosacea: Enough evidence to be convinced—What's next?

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-03-25
DOI
https://doi.org/10.1111/jdv.20552
Citations
1
Primary Topic
Acne and Rosacea Treatments and Effects
Type
article
Field-Weighted Citation Impact
2.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low‐dose isotretinoin for difficult‐to‐treat rosacea: Enough evidence to be convinced—What's next?

Esther J van Zuuren, O. Chosidow
1 citations
Journal of the European Academy of Dermatology and Venereology
Acne and Rosacea Treatments and Effects
2.00
article

Low‐dose isotretinoin for difficult‐to‐treat rosacea: Enough evidence to be convinced—What's next?

Esther J van Zuuren, O. Chosidow
article en
1 citations

Abstract

No abstract available for this paper.
Journal of the European Academy of Dermatology and VenereologyVol. 39(4)
Leiden University Medical Center (NL)
Zero hunger
Openalex Percentile: Top 17%
Acne and Rosacea Treatments and Effects
2.00
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Low‐dose isotretinoin for difficult‐to‐treat rosacea: Enough evidence to be convinced—What's next? — Esther J van Zuuren, O. Chosidow · Journal of the European Academy of Dermatology and Venereology (2025) | TGRS Research Map | TGRS